Skip to content
The DI Wire
Click Here to Subscribe to Our Free Daily News Updates

NexPoint Launches $31 Million Life Sciences DST Offering

NexPoint Launches $31 Million Life Sciences DST Offering. Alternative investments, Delaware statutory trusts, DST, NexPoint, NexPoint Life Sciences III, Kindeva, commercialization, CDMO

Reinforcing its commitment to life sciences real estate, alternative investments firm NexPoint announced the launch of NexPoint Life Sciences III Delaware Statutory Trust. The DST seeks to raise approximately $31 million from accredited investors through the offering, which is located in Woodbury, Minn.

The DST is centered on a 138,000-square-foot property in Woodbury, Minn. that serves as the global headquarters for Kindeva Drug Delivery, a contract development and manufacturing organization that develops and manufactures products across a range of complex drug-delivery formats. The property is a research, formulation, and development facility for Kindeva, which offers clinical manufacturing space, development laboratory space, and a range of features and capabilities to support drug delivery solutions. According to NexPoint, the DST investment will benefit from Kindeva’s global client base and triple-net lease term.

“Within life sciences, we see long-term value in facilities that support the growth of high-demand biomanufacturing,” said Matt McGraner, chief investment officer for NexPoint Real Estate Advisors.

“CDMOs play a major role in that, [by] helping life sciences companies reduce time to market, increase capacity, and successfully navigate the path to commercialization, making opportunities to invest in CDMO-operated facilities especially compelling,” said McGraner.

Several key factors continue to drive demand for life sciences properties, according to NexPoint. Within the CDMO space, broad initiatives to re-shore biomanufacturing and other life sciences production activities to the U.S. have created significant demand for cutting-edge manufacturing facilities across the nation. The time and resources needed to create dedicated facilities for life sciences manufacturing leads many companies to look to CDMOs to support domestic production activities.

NexPoint is comprised of a group of affiliated investment advisers and sponsors, a broker-dealer, and a suite of related investment vehicles. Based in Dallas, NexPoint provides access to alternatives through a range of investment solutions, including public and private real estate investment trusts, tax-advantaged real estate vehicles, merger arbitrage and event driven strategies, other private real estate investments, closed-end funds, interval funds, and a business development company.

Click here to visit The DI Wire directory page.